MR-anti-protein blocker and gene therapy
AUTHORS : Fuzailov B.N. | Kim P.N.
RELEVANT UNIVERSITIES : Moscow, Russia
YEAR : 2006
Let us touch a little on the question of the use of the drug “MP-anti-protein blocker”, namely, the mechanism of its work. As previously reported, the drug is
prepared from native tissue (tumor tissue) using a specific technology and is a genetically modified tumor cells working at the genetic level. Over the past year,
the use of the drug was recorded in more than 100 cases. In almost all cases
destruction of the tumor was noted
